betulinic acid has been researched along with ic9564 in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, CH; Dang, Z; Ho, P; Huang, L; Lai, W; Lee, KH; Qian, K | 1 |
| Lee, KH | 1 |
| Chen, CH; Holz-Smith, SL; Jin, L; Lee, KH; Matthews, TJ; Sun, IC | 1 |
| Chen, CH; Kashiwada, Y; Lee, KH; Sun, IC; Wang, HK; Wu, JH | 1 |
| Chen, CH; Ho, P; Huang, L; Lai, W; Li, Z; Montefiori, D | 1 |
1 review(s) available for betulinic acid and ic9564
| Article | Year |
|---|---|
Discovery and development of natural product-derived chemotherapeutic agents based on a medicinal chemistry approach.
Topics: Anti-HIV Agents; Biological Factors; Drug Design; Molecular Structure; Pharmaceutical Preparations; Plants, Medicinal | 2010 |
4 other study(ies) available for betulinic acid and ic9564
| Article | Year |
|---|---|
Betulinic acid derivatives as human immunodeficiency virus type 2 (HIV-2) inhibitors.
Topics: Anti-HIV Agents; Betulinic Acid; Cell Line; Dose-Response Relationship, Drug; HIV-1; HIV-2; Humans; Inhibitory Concentration 50; Pentacyclic Triterpenes; Triterpenes | 2009 |
Role of human immunodeficiency virus (HIV) type 1 envelope in the anti-HIV activity of the betulinic acid derivative IC9564.
Topics: Anti-HIV Agents; Betulinic Acid; Cell Fusion; Cells, Cultured; Cloning, Molecular; Drug Resistance, Microbial; HIV Envelope Protein gp120; HIV Envelope Protein gp41; HIV-1; Humans; Mutagenesis; Pentacyclic Triterpenes; Phenotype; T-Lymphocytes; Triterpenes | 2001 |
Anti-AIDS agents 49. Synthesis, anti-HIV, and anti-fusion activities of IC9564 analogues based on betulinic acid.
Topics: Amides; Animals; Anti-HIV Agents; Betulinic Acid; Chlorocebus aethiops; COS Cells; HIV Fusion Inhibitors; HIV-1; Leucine; Membrane Fusion; Pentacyclic Triterpenes; Structure-Activity Relationship; Triterpenes | 2002 |
Betulinic acid derivatives that target gp120 and inhibit multiple genetic subtypes of human immunodeficiency virus type 1.
Topics: Animals; Anti-HIV Agents; Betulinic Acid; Cell Line; Chlorocebus aethiops; COS Cells; Drug Resistance, Viral; HIV Envelope Protein gp120; HIV Fusion Inhibitors; HIV-1; Humans; Membrane Fusion; Microbial Sensitivity Tests; Models, Molecular; Pentacyclic Triterpenes; Peptide Fragments; Triterpenes | 2008 |